Chengdu Bright Eye Hospital Co. Ltd.
Bright Eye Hospital Group Co., Ltd., a specialized chain medical institution company, engages in the provision of ophthalmic general medical services in China. Its ophthalmology institutions provide diagnosis, treatment, health care, medical optometry, glasses, and other general ophthalmic medical services for patients with ophthalmic diseases in the areas of refractive surgery, cataract, ophthal… Read more
Chengdu Bright Eye Hospital Co. Ltd. (301239) - Net Assets
Latest net assets as of June 2025: CN¥2.15 Billion CNY
Based on the latest financial reports, Chengdu Bright Eye Hospital Co. Ltd. (301239) has net assets worth CN¥2.15 Billion CNY as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥4.61 Billion) and total liabilities (CN¥2.46 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥2.15 Billion |
| % of Total Assets | 46.55% |
| Annual Growth Rate | 23.29% |
| 5-Year Change | 148.6% |
| 10-Year Change | N/A |
| Growth Volatility | 45.03 |
Chengdu Bright Eye Hospital Co. Ltd. - Net Assets Trend (2019–2024)
This chart illustrates how Chengdu Bright Eye Hospital Co. Ltd.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Chengdu Bright Eye Hospital Co. Ltd. (2019–2024)
The table below shows the annual net assets of Chengdu Bright Eye Hospital Co. Ltd. from 2019 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥2.12 Billion | -8.50% |
| 2023-12-31 | CN¥2.32 Billion | +12.13% |
| 2022-12-31 | CN¥2.07 Billion | +118.02% |
| 2021-12-31 | CN¥948.30 Million | +11.14% |
| 2020-12-31 | CN¥853.25 Million | +14.64% |
| 2019-12-31 | CN¥744.32 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Chengdu Bright Eye Hospital Co. Ltd.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 27066527453.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥225.92 Million | 10.75% |
| Other Components | CN¥1.88 Billion | 89.25% |
| Total Equity | CN¥2.10 Billion | 100.00% |
Chengdu Bright Eye Hospital Co. Ltd. Competitors by Market Cap
The table below lists competitors of Chengdu Bright Eye Hospital Co. Ltd. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Cyber_Folks S.A.
WAR:CBF
|
$342.24 Million |
|
BCI Minerals Ltd
AU:BCI
|
$342.29 Million |
|
Sunmax Biotechnology Co Ltd
TWO:4728
|
$342.29 Million |
|
Jiangsu Canlon Building Materials Co Ltd
SHE:300715
|
$342.32 Million |
|
YIT Oyj
HE:YIT
|
$342.19 Million |
|
Nichidenbo Corp
TW:3090
|
$342.02 Million |
|
China Development Bank Financial Leasing Co. Ltd
F:2C6
|
$341.98 Million |
|
Beijing E-techstar Co Ltd
SHE:300513
|
$341.95 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Chengdu Bright Eye Hospital Co. Ltd.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 2,291,622,601 to 2,101,497,553, a change of -190,125,049 (-8.3%).
- Net loss of 101,862,128 reduced equity.
- Dividend payments of 77,973,389 reduced retained earnings.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥-101.86 Million | -4.85% |
| Dividends Paid | CN¥77.97 Million | -3.71% |
| Other Changes | CN¥-10.29 Million | -0.49% |
| Total Change | CN¥- | -8.30% |
Book Value vs Market Value Analysis
This analysis compares Chengdu Bright Eye Hospital Co. Ltd.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.55x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 5.40x to 2.55x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | CN¥6.63 | CN¥35.85 | x |
| 2020-12-31 | CN¥7.60 | CN¥35.85 | x |
| 2021-12-31 | CN¥8.45 | CN¥35.85 | x |
| 2022-12-31 | CN¥13.82 | CN¥35.85 | x |
| 2023-12-31 | CN¥15.32 | CN¥35.85 | x |
| 2024-12-31 | CN¥14.05 | CN¥35.85 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Chengdu Bright Eye Hospital Co. Ltd. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -4.85%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -3.80%
- • Asset Turnover: 0.58x
- • Equity Multiplier: 2.19x
- Recent ROE (-4.85%) is below the historical average (6.18%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 6.59% | 4.11% | 1.22x | 1.31x | CN¥-25.38 Million |
| 2020 | 12.77% | 8.00% | 0.66x | 2.43x | CN¥23.61 Million |
| 2021 | 9.90% | 5.49% | 0.74x | 2.45x | CN¥-940.79K |
| 2022 | 0.99% | 1.19% | 0.47x | 1.78x | CN¥-186.18 Million |
| 2023 | 11.69% | 9.86% | 0.56x | 2.10x | CN¥38.75 Million |
| 2024 | -4.85% | -3.80% | 0.58x | 2.19x | CN¥-312.01 Million |
Industry Comparison
This section compares Chengdu Bright Eye Hospital Co. Ltd.'s net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $2,852,688,731
- Average return on equity (ROE) among peers: 10.90%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Chengdu Bright Eye Hospital Co. Ltd. (301239) | CN¥2.15 Billion | 6.59% | 1.15x | $342.22 Million |
| Xian International Medical Investment Co Ltd (000516) | $3.50 Billion | 5.76% | 0.59x | $1.03 Billion |
| Meinian Onehealth Healthcare Holdings Co Ltd (002044) | $347.62 Million | 6.68% | 0.24x | $2.93 Billion |
| Hengkang Medical Group Co Ltd (002219) | $414.18 Million | 15.93% | 0.24x | $692.82 Million |
| Aier Eye Hospital Group (300015) | $12.22 Billion | 19.01% | 0.79x | $5.88 Billion |
| Liaoning He Eye Hospital Group Co. LTD. (301103) | $1.88 Billion | -1.46% | 0.18x | $159.92 Million |
| Huaxia Eye Hospital Group Co. Ltd. A (301267) | $1.85 Billion | 24.61% | 0.74x | $385.79 Million |
| Sanbo Hospital Management Group Ltd. A (301293) | $2.51 Billion | 3.12% | 0.25x | $1.52 Billion |
| Top Choice Medical Investment Co Inc (600763) | $100.20 Million | 13.53% | 0.09x | $1.69 Billion |